203 related articles for article (PubMed ID: 1055308)
1. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
2. Sensitivity and specificity of blood and thyroid radio-iodine assays for TSH and LATS and inhibitory effect of corticosteroid.
Sharard A
N Z Med J; 1975 Jan; 81(531):21-2. PubMed ID: 1055309
[No Abstract] [Full Text] [Related]
3. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
[No Abstract] [Full Text] [Related]
4. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
5. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
6. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
Beall GN; Solomon DH
J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
[No Abstract] [Full Text] [Related]
7. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
8. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
9. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
10. The long-acting thyroid stimulator.
Munro DS
Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
[No Abstract] [Full Text] [Related]
11. Clinical significance of LATS and TSH in the blood.
Lemarchand-Béraud T; Griessen M; Scazziga BR
Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
[No Abstract] [Full Text] [Related]
12. A modified bioassay for thyroid-stimulating hormone and long-acting thyroid stimulator.
Nutt J; Humphreys K; Clark F
J Endocrinol; 1974 Oct; 63(1):5-12. PubMed ID: 4418898
[No Abstract] [Full Text] [Related]
13. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
14. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
15. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
Mertz DP; Stelzer M
Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
[No Abstract] [Full Text] [Related]
16. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
17. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
Bonnyns M
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
[No Abstract] [Full Text] [Related]
18. Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania.
Vidor GI; Stewart JC; Wall JR; Wangel A; Hetzel BS
J Clin Endocrinol Metab; 1973 Dec; 37(6):901-9. PubMed ID: 4753432
[No Abstract] [Full Text] [Related]
19. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
20. Pituitary-thyroid function in thyrotoxic patients in relation to long-acting thyroid stimulator (LATS) levels.
Fukuchi M; Matsuoka T; Inoue T; Miyai K; Kumahara Y
Acta Endocrinol (Copenh); 1970 Dec; 65(4):577-82. PubMed ID: 5536685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
